Global Long-acting Weight Loss Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Long-acting Weight Loss Drugs market size was valued at US$ 4108.7 million in 2022. With growing demand in downstream market, the Long-acting Weight Loss Drugs is forecast to a readjusted size of US$ 6443.4 million by 2029 with a CAGR of 6.6% during review period.
The research report highlights the growth potential of the global Long-acting Weight Loss Drugs market. Long-acting Weight Loss Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-acting Weight Loss Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-acting Weight Loss Drugs market.
Long-acting weight loss drugs, also known as extended-release or sustained-release weight loss medications, are pharmaceuticals designed to help individuals manage their weight by reducing appetite, increasing feelings of fullness, or altering the body's metabolism over an extended period. These drugs are formulated to provide more sustained effects, allowing for less frequent dosing. It's essential to note that these medications are typically prescribed under the guidance of a healthcare professional and are intended for use as part of a comprehensive weight management program.
The market for long-acting weight loss drugs is experiencing rapid growth, driven by global concerns about obesity and an ongoing pursuit of healthy lifestyles. The market size has significantly expanded, with increasing sales. The specific uses of long-acting weight loss drugs primarily involve assisting individuals who struggle to achieve their ideal weight through traditional methods. These drugs work by regulating appetite, promoting metabolism, or affecting energy absorption to achieve long-term weight loss. In the future, with ongoing technological innovations and an increasing awareness of health, the development and application of long-acting weight loss drugs are expected to continue progressing, offering more solutions to the global obesity issue.
Key Features:
The report on Long-acting Weight Loss Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-acting Weight Loss Drugs market. It may include historical data, market segmentation by Type (e.g., Orlistat, Semaglutide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-acting Weight Loss Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-acting Weight Loss Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-acting Weight Loss Drugs industry. This include advancements in Long-acting Weight Loss Drugs technology, Long-acting Weight Loss Drugs new entrants, Long-acting Weight Loss Drugs new investment, and other innovations that are shaping the future of Long-acting Weight Loss Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-acting Weight Loss Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Long-acting Weight Loss Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-acting Weight Loss Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-acting Weight Loss Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-acting Weight Loss Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-acting Weight Loss Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-acting Weight Loss Drugs market.
Market Segmentation:
Long-acting Weight Loss Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Long-acting Weight Loss Drugs market?
What factors are driving Long-acting Weight Loss Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting Weight Loss Drugs market opportunities vary by end market size?
How does Long-acting Weight Loss Drugs break out type, application?
According to our LPI (LP Information) latest study, the global Long-acting Weight Loss Drugs market size was valued at US$ 4108.7 million in 2022. With growing demand in downstream market, the Long-acting Weight Loss Drugs is forecast to a readjusted size of US$ 6443.4 million by 2029 with a CAGR of 6.6% during review period.
The research report highlights the growth potential of the global Long-acting Weight Loss Drugs market. Long-acting Weight Loss Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-acting Weight Loss Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-acting Weight Loss Drugs market.
Long-acting weight loss drugs, also known as extended-release or sustained-release weight loss medications, are pharmaceuticals designed to help individuals manage their weight by reducing appetite, increasing feelings of fullness, or altering the body's metabolism over an extended period. These drugs are formulated to provide more sustained effects, allowing for less frequent dosing. It's essential to note that these medications are typically prescribed under the guidance of a healthcare professional and are intended for use as part of a comprehensive weight management program.
The market for long-acting weight loss drugs is experiencing rapid growth, driven by global concerns about obesity and an ongoing pursuit of healthy lifestyles. The market size has significantly expanded, with increasing sales. The specific uses of long-acting weight loss drugs primarily involve assisting individuals who struggle to achieve their ideal weight through traditional methods. These drugs work by regulating appetite, promoting metabolism, or affecting energy absorption to achieve long-term weight loss. In the future, with ongoing technological innovations and an increasing awareness of health, the development and application of long-acting weight loss drugs are expected to continue progressing, offering more solutions to the global obesity issue.
Key Features:
The report on Long-acting Weight Loss Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-acting Weight Loss Drugs market. It may include historical data, market segmentation by Type (e.g., Orlistat, Semaglutide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-acting Weight Loss Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-acting Weight Loss Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-acting Weight Loss Drugs industry. This include advancements in Long-acting Weight Loss Drugs technology, Long-acting Weight Loss Drugs new entrants, Long-acting Weight Loss Drugs new investment, and other innovations that are shaping the future of Long-acting Weight Loss Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-acting Weight Loss Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Long-acting Weight Loss Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-acting Weight Loss Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-acting Weight Loss Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-acting Weight Loss Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-acting Weight Loss Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-acting Weight Loss Drugs market.
Market Segmentation:
Long-acting Weight Loss Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Orlistat
- Semaglutide
- Liraglutide
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Roche
- GSK
- Vivus
- Arena
- Orexigen
What is the 10-year outlook for the global Long-acting Weight Loss Drugs market?
What factors are driving Long-acting Weight Loss Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting Weight Loss Drugs market opportunities vary by end market size?
How does Long-acting Weight Loss Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Weight Loss Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Long-acting Weight Loss Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Long-acting Weight Loss Drugs by Country/Region, 2018, 2022 & 2029
2.2 Long-acting Weight Loss Drugs Segment by Type
2.2.1 Orlistat
2.2.2 Semaglutide
2.2.3 Liraglutide
2.2.4 Other
2.3 Long-acting Weight Loss Drugs Sales by Type
2.3.1 Global Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Long-acting Weight Loss Drugs Sale Price by Type (2018-2023)
2.4 Long-acting Weight Loss Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Long-acting Weight Loss Drugs Sales by Application
2.5.1 Global Long-acting Weight Loss Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Long-acting Weight Loss Drugs Sale Price by Application (2018-2023)
3 GLOBAL LONG-ACTING WEIGHT LOSS DRUGS BY COMPANY
3.1 Global Long-acting Weight Loss Drugs Breakdown Data by Company
3.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Long-acting Weight Loss Drugs Sales Market Share by Company (2018-2023)
3.2 Global Long-acting Weight Loss Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Long-acting Weight Loss Drugs Revenue by Company (2018-2023)
3.2.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Long-acting Weight Loss Drugs Sale Price by Company
3.4 Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Weight Loss Drugs Product Location Distribution
3.4.2 Players Long-acting Weight Loss Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Weight Loss Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Long-acting Weight Loss Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Long-acting Weight Loss Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Long-acting Weight Loss Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Long-acting Weight Loss Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Long-acting Weight Loss Drugs Sales Growth
4.4 APAC Long-acting Weight Loss Drugs Sales Growth
4.5 Europe Long-acting Weight Loss Drugs Sales Growth
4.6 Middle East & Africa Long-acting Weight Loss Drugs Sales Growth
5 AMERICAS
5.1 Americas Long-acting Weight Loss Drugs Sales by Country
5.1.1 Americas Long-acting Weight Loss Drugs Sales by Country (2018-2023)
5.1.2 Americas Long-acting Weight Loss Drugs Revenue by Country (2018-2023)
5.2 Americas Long-acting Weight Loss Drugs Sales by Type
5.3 Americas Long-acting Weight Loss Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Weight Loss Drugs Sales by Region
6.1.1 APAC Long-acting Weight Loss Drugs Sales by Region (2018-2023)
6.1.2 APAC Long-acting Weight Loss Drugs Revenue by Region (2018-2023)
6.2 APAC Long-acting Weight Loss Drugs Sales by Type
6.3 APAC Long-acting Weight Loss Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Weight Loss Drugs by Country
7.1.1 Europe Long-acting Weight Loss Drugs Sales by Country (2018-2023)
7.1.2 Europe Long-acting Weight Loss Drugs Revenue by Country (2018-2023)
7.2 Europe Long-acting Weight Loss Drugs Sales by Type
7.3 Europe Long-acting Weight Loss Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Weight Loss Drugs by Country
8.1.1 Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Long-acting Weight Loss Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Long-acting Weight Loss Drugs Sales by Type
8.3 Middle East & Africa Long-acting Weight Loss Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs
10.3 Manufacturing Process Analysis of Long-acting Weight Loss Drugs
10.4 Industry Chain Structure of Long-acting Weight Loss Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Weight Loss Drugs Distributors
11.3 Long-acting Weight Loss Drugs Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
12.1 Global Long-acting Weight Loss Drugs Market Size Forecast by Region
12.1.1 Global Long-acting Weight Loss Drugs Forecast by Region (2024-2029)
12.1.2 Global Long-acting Weight Loss Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-acting Weight Loss Drugs Forecast by Type
12.7 Global Long-acting Weight Loss Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.2.3 Roche Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.3.3 GSK Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Vivus
13.4.1 Vivus Company Information
13.4.2 Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.4.3 Vivus Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Vivus Main Business Overview
13.4.5 Vivus Latest Developments
13.5 Arena
13.5.1 Arena Company Information
13.5.2 Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.5.3 Arena Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Arena Main Business Overview
13.5.5 Arena Latest Developments
13.6 Orexigen
13.6.1 Orexigen Company Information
13.6.2 Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.6.3 Orexigen Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Orexigen Main Business Overview
13.6.5 Orexigen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Weight Loss Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Long-acting Weight Loss Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Long-acting Weight Loss Drugs by Country/Region, 2018, 2022 & 2029
2.2 Long-acting Weight Loss Drugs Segment by Type
2.2.1 Orlistat
2.2.2 Semaglutide
2.2.3 Liraglutide
2.2.4 Other
2.3 Long-acting Weight Loss Drugs Sales by Type
2.3.1 Global Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Long-acting Weight Loss Drugs Sale Price by Type (2018-2023)
2.4 Long-acting Weight Loss Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Long-acting Weight Loss Drugs Sales by Application
2.5.1 Global Long-acting Weight Loss Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Long-acting Weight Loss Drugs Sale Price by Application (2018-2023)
3 GLOBAL LONG-ACTING WEIGHT LOSS DRUGS BY COMPANY
3.1 Global Long-acting Weight Loss Drugs Breakdown Data by Company
3.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Long-acting Weight Loss Drugs Sales Market Share by Company (2018-2023)
3.2 Global Long-acting Weight Loss Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Long-acting Weight Loss Drugs Revenue by Company (2018-2023)
3.2.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Long-acting Weight Loss Drugs Sale Price by Company
3.4 Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Weight Loss Drugs Product Location Distribution
3.4.2 Players Long-acting Weight Loss Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Weight Loss Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Long-acting Weight Loss Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Long-acting Weight Loss Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Long-acting Weight Loss Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Long-acting Weight Loss Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Long-acting Weight Loss Drugs Sales Growth
4.4 APAC Long-acting Weight Loss Drugs Sales Growth
4.5 Europe Long-acting Weight Loss Drugs Sales Growth
4.6 Middle East & Africa Long-acting Weight Loss Drugs Sales Growth
5 AMERICAS
5.1 Americas Long-acting Weight Loss Drugs Sales by Country
5.1.1 Americas Long-acting Weight Loss Drugs Sales by Country (2018-2023)
5.1.2 Americas Long-acting Weight Loss Drugs Revenue by Country (2018-2023)
5.2 Americas Long-acting Weight Loss Drugs Sales by Type
5.3 Americas Long-acting Weight Loss Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Weight Loss Drugs Sales by Region
6.1.1 APAC Long-acting Weight Loss Drugs Sales by Region (2018-2023)
6.1.2 APAC Long-acting Weight Loss Drugs Revenue by Region (2018-2023)
6.2 APAC Long-acting Weight Loss Drugs Sales by Type
6.3 APAC Long-acting Weight Loss Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Weight Loss Drugs by Country
7.1.1 Europe Long-acting Weight Loss Drugs Sales by Country (2018-2023)
7.1.2 Europe Long-acting Weight Loss Drugs Revenue by Country (2018-2023)
7.2 Europe Long-acting Weight Loss Drugs Sales by Type
7.3 Europe Long-acting Weight Loss Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Weight Loss Drugs by Country
8.1.1 Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Long-acting Weight Loss Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Long-acting Weight Loss Drugs Sales by Type
8.3 Middle East & Africa Long-acting Weight Loss Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs
10.3 Manufacturing Process Analysis of Long-acting Weight Loss Drugs
10.4 Industry Chain Structure of Long-acting Weight Loss Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Weight Loss Drugs Distributors
11.3 Long-acting Weight Loss Drugs Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
12.1 Global Long-acting Weight Loss Drugs Market Size Forecast by Region
12.1.1 Global Long-acting Weight Loss Drugs Forecast by Region (2024-2029)
12.1.2 Global Long-acting Weight Loss Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-acting Weight Loss Drugs Forecast by Type
12.7 Global Long-acting Weight Loss Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.2.3 Roche Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.3.3 GSK Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Vivus
13.4.1 Vivus Company Information
13.4.2 Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.4.3 Vivus Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Vivus Main Business Overview
13.4.5 Vivus Latest Developments
13.5 Arena
13.5.1 Arena Company Information
13.5.2 Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.5.3 Arena Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Arena Main Business Overview
13.5.5 Arena Latest Developments
13.6 Orexigen
13.6.1 Orexigen Company Information
13.6.2 Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.6.3 Orexigen Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Orexigen Main Business Overview
13.6.5 Orexigen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting Weight Loss Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Long-acting Weight Loss Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Orlistat
Table 4. Major Players of Semaglutide
Table 5. Major Players of Liraglutide
Table 6. Major Players of Other
Table 7. Global Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Long-acting Weight Loss Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Long-acting Weight Loss Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Long-acting Weight Loss Drugs Revenue by Application (2018-2023)
Table 15. Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Long-acting Weight Loss Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Long-acting Weight Loss Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Long-acting Weight Loss Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Long-acting Weight Loss Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Long-acting Weight Loss Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution and Sales Area
Table 23. Players Long-acting Weight Loss Drugs Products Offered
Table 24. Long-acting Weight Loss Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Long-acting Weight Loss Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Long-acting Weight Loss Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Long-acting Weight Loss Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Long-acting Weight Loss Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Long-acting Weight Loss Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Long-acting Weight Loss Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Long-acting Weight Loss Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Long-acting Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Long-acting Weight Loss Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Long-acting Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Long-acting Weight Loss Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Long-acting Weight Loss Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Long-acting Weight Loss Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Long-acting Weight Loss Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Long-acting Weight Loss Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Long-acting Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Long-acting Weight Loss Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Long-acting Weight Loss Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Long-acting Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Long-acting Weight Loss Drugs
Table 60. Key Market Challenges & Risks of Long-acting Weight Loss Drugs
Table 61. Key Industry Trends of Long-acting Weight Loss Drugs
Table 62. Long-acting Weight Loss Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Long-acting Weight Loss Drugs Distributors List
Table 65. Long-acting Weight Loss Drugs Customer List
Table 66. Global Long-acting Weight Loss Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Long-acting Weight Loss Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Long-acting Weight Loss Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Long-acting Weight Loss Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Long-acting Weight Loss Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Long-acting Weight Loss Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Long-acting Weight Loss Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Long-acting Weight Loss Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Long-acting Weight Loss Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Long-acting Weight Loss Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Long-acting Weight Loss Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Long-acting Weight Loss Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Long-acting Weight Loss Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Long-acting Weight Loss Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Novo Nordisk Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 82. Novo Nordisk Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novo Nordisk Main Business
Table 84. Novo Nordisk Latest Developments
Table 85. Roche Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 87. Roche Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. GSK Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 92. GSK Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GSK Main Business
Table 94. GSK Latest Developments
Table 95. Vivus Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 97. Vivus Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Vivus Main Business
Table 99. Vivus Latest Developments
Table 100. Arena Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 102. Arena Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Arena Main Business
Table 104. Arena Latest Developments
Table 105. Orexigen Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 107. Orexigen Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Orexigen Main Business
Table 109. Orexigen Latest Developments
Table 1. Long-acting Weight Loss Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Long-acting Weight Loss Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Orlistat
Table 4. Major Players of Semaglutide
Table 5. Major Players of Liraglutide
Table 6. Major Players of Other
Table 7. Global Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Long-acting Weight Loss Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Long-acting Weight Loss Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Long-acting Weight Loss Drugs Revenue by Application (2018-2023)
Table 15. Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Long-acting Weight Loss Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Long-acting Weight Loss Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Long-acting Weight Loss Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Long-acting Weight Loss Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Long-acting Weight Loss Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution and Sales Area
Table 23. Players Long-acting Weight Loss Drugs Products Offered
Table 24. Long-acting Weight Loss Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Long-acting Weight Loss Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Long-acting Weight Loss Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Long-acting Weight Loss Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Long-acting Weight Loss Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Long-acting Weight Loss Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Long-acting Weight Loss Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Long-acting Weight Loss Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Long-acting Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Long-acting Weight Loss Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Long-acting Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Long-acting Weight Loss Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Long-acting Weight Loss Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Long-acting Weight Loss Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Long-acting Weight Loss Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Long-acting Weight Loss Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Long-acting Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Long-acting Weight Loss Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Long-acting Weight Loss Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Long-acting Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Long-acting Weight Loss Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Long-acting Weight Loss Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Long-acting Weight Loss Drugs
Table 60. Key Market Challenges & Risks of Long-acting Weight Loss Drugs
Table 61. Key Industry Trends of Long-acting Weight Loss Drugs
Table 62. Long-acting Weight Loss Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Long-acting Weight Loss Drugs Distributors List
Table 65. Long-acting Weight Loss Drugs Customer List
Table 66. Global Long-acting Weight Loss Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Long-acting Weight Loss Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Long-acting Weight Loss Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Long-acting Weight Loss Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Long-acting Weight Loss Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Long-acting Weight Loss Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Long-acting Weight Loss Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Long-acting Weight Loss Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Long-acting Weight Loss Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Long-acting Weight Loss Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Long-acting Weight Loss Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Long-acting Weight Loss Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Long-acting Weight Loss Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Long-acting Weight Loss Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Novo Nordisk Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 82. Novo Nordisk Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novo Nordisk Main Business
Table 84. Novo Nordisk Latest Developments
Table 85. Roche Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 87. Roche Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. GSK Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 92. GSK Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GSK Main Business
Table 94. GSK Latest Developments
Table 95. Vivus Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 97. Vivus Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Vivus Main Business
Table 99. Vivus Latest Developments
Table 100. Arena Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 102. Arena Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Arena Main Business
Table 104. Arena Latest Developments
Table 105. Orexigen Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 107. Orexigen Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Orexigen Main Business
Table 109. Orexigen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting Weight Loss Drugs
Figure 2. Long-acting Weight Loss Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Weight Loss Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Long-acting Weight Loss Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Long-acting Weight Loss Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Orlistat
Figure 10. Product Picture of Semaglutide
Figure 11. Product Picture of Liraglutide
Figure 12. Product Picture of Other
Figure 13. Global Long-acting Weight Loss Drugs Sales Market Share by Type in 2022
Figure 14. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Long-acting Weight Loss Drugs Consumed in Hospital
Figure 16. Global Long-acting Weight Loss Drugs Market: Hospital (2018-2023) & (K Units)
Figure 17. Long-acting Weight Loss Drugs Consumed in Clinic
Figure 18. Global Long-acting Weight Loss Drugs Market: Clinic (2018-2023) & (K Units)
Figure 19. Long-acting Weight Loss Drugs Consumed in Other
Figure 20. Global Long-acting Weight Loss Drugs Market: Other (2018-2023) & (K Units)
Figure 21. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2022)
Figure 22. Global Long-acting Weight Loss Drugs Revenue Market Share by Application in 2022
Figure 23. Long-acting Weight Loss Drugs Sales Market by Company in 2022 (K Units)
Figure 24. Global Long-acting Weight Loss Drugs Sales Market Share by Company in 2022
Figure 25. Long-acting Weight Loss Drugs Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Long-acting Weight Loss Drugs Revenue Market Share by Company in 2022
Figure 27. Global Long-acting Weight Loss Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 30. Americas Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 31. APAC Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 32. APAC Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Europe Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 34. Europe Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Americas Long-acting Weight Loss Drugs Sales Market Share by Country in 2022
Figure 38. Americas Long-acting Weight Loss Drugs Revenue Market Share by Country in 2022
Figure 39. Americas Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 40. Americas Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 41. United States Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Long-acting Weight Loss Drugs Sales Market Share by Region in 2022
Figure 46. APAC Long-acting Weight Loss Drugs Revenue Market Share by Regions in 2022
Figure 47. APAC Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 48. APAC Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 49. China Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Long-acting Weight Loss Drugs Sales Market Share by Country in 2022
Figure 57. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country in 2022
Figure 58. Europe Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 59. Europe Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 60. Germany Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Long-acting Weight Loss Drugs Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 69. Egypt Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs in 2022
Figure 75. Manufacturing Process Analysis of Long-acting Weight Loss Drugs
Figure 76. Industry Chain Structure of Long-acting Weight Loss Drugs
Figure 77. Channels of Distribution
Figure 78. Global Long-acting Weight Loss Drugs Sales Market Forecast by Region (2024-2029)
Figure 79. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Long-acting Weight Loss Drugs
Figure 2. Long-acting Weight Loss Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Weight Loss Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Long-acting Weight Loss Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Long-acting Weight Loss Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Orlistat
Figure 10. Product Picture of Semaglutide
Figure 11. Product Picture of Liraglutide
Figure 12. Product Picture of Other
Figure 13. Global Long-acting Weight Loss Drugs Sales Market Share by Type in 2022
Figure 14. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Long-acting Weight Loss Drugs Consumed in Hospital
Figure 16. Global Long-acting Weight Loss Drugs Market: Hospital (2018-2023) & (K Units)
Figure 17. Long-acting Weight Loss Drugs Consumed in Clinic
Figure 18. Global Long-acting Weight Loss Drugs Market: Clinic (2018-2023) & (K Units)
Figure 19. Long-acting Weight Loss Drugs Consumed in Other
Figure 20. Global Long-acting Weight Loss Drugs Market: Other (2018-2023) & (K Units)
Figure 21. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2022)
Figure 22. Global Long-acting Weight Loss Drugs Revenue Market Share by Application in 2022
Figure 23. Long-acting Weight Loss Drugs Sales Market by Company in 2022 (K Units)
Figure 24. Global Long-acting Weight Loss Drugs Sales Market Share by Company in 2022
Figure 25. Long-acting Weight Loss Drugs Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Long-acting Weight Loss Drugs Revenue Market Share by Company in 2022
Figure 27. Global Long-acting Weight Loss Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 30. Americas Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 31. APAC Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 32. APAC Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Europe Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 34. Europe Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Long-acting Weight Loss Drugs Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Long-acting Weight Loss Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Americas Long-acting Weight Loss Drugs Sales Market Share by Country in 2022
Figure 38. Americas Long-acting Weight Loss Drugs Revenue Market Share by Country in 2022
Figure 39. Americas Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 40. Americas Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 41. United States Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Long-acting Weight Loss Drugs Sales Market Share by Region in 2022
Figure 46. APAC Long-acting Weight Loss Drugs Revenue Market Share by Regions in 2022
Figure 47. APAC Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 48. APAC Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 49. China Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Long-acting Weight Loss Drugs Sales Market Share by Country in 2022
Figure 57. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country in 2022
Figure 58. Europe Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 59. Europe Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 60. Germany Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Long-acting Weight Loss Drugs Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Application (2018-2023)
Figure 69. Egypt Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Long-acting Weight Loss Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs in 2022
Figure 75. Manufacturing Process Analysis of Long-acting Weight Loss Drugs
Figure 76. Industry Chain Structure of Long-acting Weight Loss Drugs
Figure 77. Channels of Distribution
Figure 78. Global Long-acting Weight Loss Drugs Sales Market Forecast by Region (2024-2029)
Figure 79. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Application (2024-2029)
